Sartorius and Bosch Announce Global Collaboration for Aseptic Filling Equipment for Drug Products
By LabMedica International staff writers Posted on 02 Jul 2012 |
Image: The PreVAS aseptic filling system (Photo courtesy of Bosch / Sartorius Stedim Biotech).
Sartorius Stedim Biotech (SSB; Aubagne, France), an international pharma and biotech supplier, and Bosch Packaging Technology (Waiblingen, Germany), one of the leading providers of process technology and packaging solutions for the pharmaceutical industry, announced a long-term global partnership agreement. The agreement covers the mutual design and development of single-use filling solutions to be used on Bosch’s aseptic filling equipment for final fill-and-finish operations of drug products.
SSB will provide Bosch with preconfigured single-use filling transfer sets, consisting of bags, filters, tubing, and connectors. Bosch will combine them with its aseptic filling and barrier isolation technology into new, novel systems for aseptic filling, and exclusively market, distribute, and service these new filling systems under its own brand name.
With the new product line PreVAS (prevalidated, preassembled, presterilized), Bosch will supply its customers with highly cost effective, plug and play tools for aseptic filling operations that provide additional flexibility and come along with comprehensive validation packages. PreVAS will be launched at Achema 2012, held in June 2012 in Frankfurt (Germany).
Joachim Brenner, responsible for Bosch’s pharma liquid product range worldwide and site manager of the plant Crailsheim, stated, “By integrating SSB’s single-use technologies into our aseptic filling systems, we are expanding our product and service portfolio in the area of fill-and-finish unit operations by an important component. With our joint expertise, we intend to develop configurable and customized single-use filling solutions and to provide strong validation and technical support.”
Jean-Marc Cappia, vice president of marketing, fluid management technologies, at SSB, stated, “The partnership with Bosch promotes the implementation of single-use technologies into critical applications such as final filling operations and strengthens the confidence into single-use technology. Our customers from the pharmaceutical and biopharmaceutical industry are facing mounting cost pressure and time constraints. By integrating single-use technology into fill-and-finish unit operations, they can handle smaller batches and product change overs in a safe, economic and flexible way.”
Sartorius Stedim Biotech is a provider of equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management, and lab technologies are supporting the biopharmaceutical industry worldwide to develop drugs safely and cost-effectively.
Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. The company’s manufacturing and R&D sites are in Europe, North America, and Asia, with a global network of sales companies. Its key manufacturing and R&D site is in Germany.
The Bosch division of Packaging Technology is a leading supplier in the field of processing and packaging technology. The company develops and produces solutions for the pharmaceutical, food, and confectionery industries.
Bosch Packaging Technology--Pharma is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, systems, and complete solutions for process technology of sterile liquids and powder processing. It also comprises primary packaging for sterile fill and finish and solid dosage forms, secondary packaging as well as inspection technology, qualification, validation services.
Related Links:
Sartorius Stedim Biotech
Bosch Packaging Technology
SSB will provide Bosch with preconfigured single-use filling transfer sets, consisting of bags, filters, tubing, and connectors. Bosch will combine them with its aseptic filling and barrier isolation technology into new, novel systems for aseptic filling, and exclusively market, distribute, and service these new filling systems under its own brand name.
With the new product line PreVAS (prevalidated, preassembled, presterilized), Bosch will supply its customers with highly cost effective, plug and play tools for aseptic filling operations that provide additional flexibility and come along with comprehensive validation packages. PreVAS will be launched at Achema 2012, held in June 2012 in Frankfurt (Germany).
Joachim Brenner, responsible for Bosch’s pharma liquid product range worldwide and site manager of the plant Crailsheim, stated, “By integrating SSB’s single-use technologies into our aseptic filling systems, we are expanding our product and service portfolio in the area of fill-and-finish unit operations by an important component. With our joint expertise, we intend to develop configurable and customized single-use filling solutions and to provide strong validation and technical support.”
Jean-Marc Cappia, vice president of marketing, fluid management technologies, at SSB, stated, “The partnership with Bosch promotes the implementation of single-use technologies into critical applications such as final filling operations and strengthens the confidence into single-use technology. Our customers from the pharmaceutical and biopharmaceutical industry are facing mounting cost pressure and time constraints. By integrating single-use technology into fill-and-finish unit operations, they can handle smaller batches and product change overs in a safe, economic and flexible way.”
Sartorius Stedim Biotech is a provider of equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management, and lab technologies are supporting the biopharmaceutical industry worldwide to develop drugs safely and cost-effectively.
Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. The company’s manufacturing and R&D sites are in Europe, North America, and Asia, with a global network of sales companies. Its key manufacturing and R&D site is in Germany.
The Bosch division of Packaging Technology is a leading supplier in the field of processing and packaging technology. The company develops and produces solutions for the pharmaceutical, food, and confectionery industries.
Bosch Packaging Technology--Pharma is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, systems, and complete solutions for process technology of sterile liquids and powder processing. It also comprises primary packaging for sterile fill and finish and solid dosage forms, secondary packaging as well as inspection technology, qualification, validation services.
Related Links:
Sartorius Stedim Biotech
Bosch Packaging Technology
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples